Position in BHC
as of Mar 31, 2026
· filed Apr 20, 2026
Position Value
$270
-$77 QoQ
Shares Held
50
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BHC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Blue Trust, Inc. holds $3,516,728 across 23 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
98,875 | $922,503 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
23,981 | $590,171 | |
| 3 | RDY |
Dr Reddys Laboratories Ltd
|
31,123 | $450,971 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
722 | $391,200 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
1,235 | $208,146 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
9,807 | $157,205 | |
| 7 | ZTS |
Zoetis Inc.
|
1,965 | $141,204 | |
| 8 | INDV |
Indivior Pharmaceuticals, Inc.
|
2,122 | $87,065 |
All Filings in BHC
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $270 | 50 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $347 | 50 | Shares | Sole | 2026-01-16 | |
| 2024-09-30 | $718 | 88 | Shares | Defined | 2024-10-17 | |
| 2024-06-30 | $446 | 64 | Shares | Defined | 2024-07-18 | |
| 2022-06-30 | $2,090 | 250 | Shares | Sole | 2022-08-09 | |
| No filing history on record for this holder in this stock. | ||||||